Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 166INDUSTRY 24NIH 22NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 30Hematologic Neoplasms 20Leukemia 13Multiple Myeloma 9Myelodysplastic Syndromes 8Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Neoplasms 7Recurrence 6Lymphoma, Non-Hodgkin 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Chronic 3Hodgkin Disease 3Vitamin D Deficiency 2Neoplasms, Plasma Cell 2Neoplasm, Residual 2Motor Activity 2Invasive Fungal Infections 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Diseases 2Cardiovascular Diseases 2Wilms Tumor 1Stomatitis 1Sprains and Strains 1Shoulder Injuries 1Shoulder Dislocation 1Sepsis 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Graft vs Host Disease × Other hematologic neoplasm × Clear all
NCT06299462 2025-02-25

PTCy and ATG for MSD and MUD Transplants

Instituto Nacional de Cancer, Brazil

Phase 1/2 Recruiting
50 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡